Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome

about

Pharmacological Therapy in Brugada Syndrome.

P2860

Q55415521-05500B9A-7EF1-438A-AE97-BAC5B99D530C

P2860

Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome

Item

http://www.wikidata.org/entity/Q35781746

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Beneficial Effects of Isoprote ...... brillation in Brugada Syndrome

@ast

Beneficial Effects of Isoprote ...... brillation in Brugada Syndrome

@en

type

Item

label

Beneficial Effects of Isoprote ...... brillation in Brugada Syndrome

@ast

Beneficial Effects of Isoprote ...... brillation in Brugada Syndrome

@en

prefLabel

Beneficial Effects of Isoprote ...... brillation in Brugada Syndrome

@ast

Beneficial Effects of Isoprote ...... brillation in Brugada Syndrome

@en

P1476

Beneficial Effects of Isoprote ...... brillation in Brugada Syndrome

@en

P2093

Ambar Patel

http://www.w3.org/2001/XMLSchema#string

Khyati Baxi

http://www.w3.org/2001/XMLSchema#string

Melissa Dakkak

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of Brugada syndrome: insights for risk stratification and management.

Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Efficacy of quinidine in high-risk patients with Brugada syndrome.

Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation.

Sudden cardiac arrest associated with early repolarization.

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui

Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3.

Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.

Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review.

Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.

P304

753537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/753537

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279231519

http://www.w3.org/2001/XMLSchema#string

P698

26171254

http://www.w3.org/2001/XMLSchema#string

P932

4480801

http://www.w3.org/2001/XMLSchema#string

Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome

about

P2860

P2860

Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932